Acciones C21 Investments Inc Toronto S.E.
Acciones
CWQ
CA23129E2069
Farmacéuticos
Ventas 2022 | 32,98 45,09 30,72 | Ventas 2023 | 28,89 39,5 26,9 | Capitalización | 30,67 M 41,93 M 28,56 M |
---|---|---|---|---|---|
Resultado Neto 2022 | 10 M 13,67 M 9,31 M | Resultado Neto 2023 | - 0 0 | VE / Ventas 2022 | 2.159.079 x |
Deuda neta 2022 | 16,47 M 22,52 M 15,34 M | Deuda neta 2023 | 10,24 M 14,01 M 9,54 M | VE / Ventas 2023 | 1.416.161 x |
P/E ratio 2022 |
4,98
x | P/E ratio 2023 |
223
x | Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 81,24 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Sonny Newman
CEO | Chief Executive Officer | - | 08/07/19 |
Michael Kidd
DFI | Director of Finance/CFO | - | 26/07/18 |
Aron Swan
COO | Chief Operating Officer | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Donald Macdonald
CHM | Chairman | - | 18/06/18 |
Leonard Werden
BRD | Director/Board Member | - | 25/07/17 |
Michael Kidd
DFI | Director of Finance/CFO | - | 26/07/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+26,93 % | 5547,48 M | |
-33,55 % | 3524,46 M | |
-3,74 % | 3029,31 M | |
-26,09 % | 2586,23 M | |
-10,93 % | 2283,89 M | |
+41,50 % | 1878,77 M | |
+41,84 % | 1459,35 M | |
-12,94 % | 1428,5 M | |
+47,62 % | 1422,11 M |